TherapeuticsMD Inc. buy stratec
Start price
26.10.18
/
50%
€242.64
Target price
04.11.21
€200.00
Performance (%)
-86.61%
End price
05.11.21
€32.50
Summary
This prediction ended on 05.11.21 with a price of €32.50. Massive losses of -86.61% were the result for the BUY prediction by stratec. stratec has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| TherapeuticsMD Inc. | -2.051% | -2.051% | 185.075% | -38.782% |
| iShares Core DAX® | -2.116% | -8.178% | -1.471% | 54.145% |
| iShares Nasdaq 100 | -1.132% | 0.908% | 19.961% | 83.323% |
| iShares Nikkei 225® | -0.658% | -6.257% | 27.473% | 53.605% |
| iShares S&P 500 | -1.261% | -1.001% | 13.631% | 62.624% |
Comments by stratec for this prediction
In the thread Therapeuticsmd Inc. diskutieren
stratec stimmt der Buy-Einschätzung der institutionellen Analysten zu
TherapeuticsMD announces that it is discussing labeling with the FDA related to hormone therapy candidate TX-001HR.
The agency's action date for its proposed use for treating moderate-to-severe vasomotor symptoms due to menopause is October 28, but a decision may be announced today.
Kursziel geändert auf 4,0
In the thread Trading Therapeuticsmd Inc.
Die von stratec gewählte maximale Laufzeit wurde überschritten